维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="Moritoki Y"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Plasmacytoid dendritic cells of different origins have distinct characteristics and function: studies of lymphoid progenitors versus myeloid progenitors 显示文摘	Yang G X Lian Z X Kikuchi K Moritoki Y Ansari A A Liu Y J	2006	Immunol2006，175，：	1
2	B -cell depletionwith anti- CD20 ameliorates autoimmune cholangitis but ex- acerbates colitis in transforming growth factor -beta receptor II dominant negative mice 显示文摘	MORITOKI Y LIAN ZX LINDOR K	2009	Hepatology2009，50，6：	1
3	Can spongioplastyprevent fistula formation and correct penile curvature in TIPurethroplasty for hypospadias? 显示文摘	Hayashi Y Mizuno K Moritoki Y	2013	Urology*2013，81，6：	1
4	Biochemical and immunologic effects of rituximab in patients with primary bili- ary cirrhosis and an incomplete response to ursodeoxycholic acid显示文摘	TSUDA M MORITOKI Y LIAN ZX	2012	Hepatology2012，55，2：	1
5	B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis 显示文摘	MORITOKI Y ZHANG W TSUNEYAMA K	2009	Gastroenterology2009，136，：	1
6	Distinctive changes in histone H3K4 modification mediated via Kdm5a expression in spermatogonial stem cells of cryptorchid testes 显示文摘	Nishio H Hayashi Y Moritoki Y	2014	J Urol2014，191，5：	1
7	AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers 显示文摘	MORITOKI Y LIAN ZX WULFF H	2007	Hepatology2007，45，2：	1
8	Biochemical and immunologic effects of rituximab in patients with primary billary cirrhosis and an incomplete response to ursodeoxycholic acid显示文摘	Tsuda M Moritoki Y Lian ZX	2012	Hepatology2012，55，2：	1
9	Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis显示文摘	Jin Q Moritoki Y Lleo A		0，，5：	1
10	Biochemical and immunologic effects of rituximab in patients with prima- ry biliary cirrhosis and an incomplete response to ursodeoxy- cholic acid显示文摘	TSUDA M MORITOKI Y LIAN ZX	2012	Hepatology2012，55，2：	1
11	IL-2 receptor alpha-/-) mice and the development of primary biliary cirrhosis显示文摘	WAKAHAYASHI K LIAN Z X MORITOKI Y	2006	Hepatology2006，44，5：	1
12	Age-related decrease in endothelium-dependent dilator response to histamine in rat mesenteric artery显示文摘	Moritoki H Hosoki E Ishida Y	1986	Eur J Pharmacol1986，126，：	1
13	Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid显示文摘	Tsuda M Moritoki Y Lian ZX	2012	Hepatology2012，55，2：	1
14	Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid显示文摘	Tsuda M Moritoki Y Lian Z X	2012	Hepatology2012，55，2：	1
15	AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers显示文摘	Moritoki Y Lian ZX Wulff H	2007	Hepatology2007，45，2：	1
16	Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid显示文摘	Tsuda M Moritoki Y Lian ZX		Hepatology0，，：	1
17	Differential expression of caveolin-3 in mouse smooth muscle cells in vivo 显示文摘	Kogo H Ito S Y Moritoki Y	2006	Cell Tissue Res2006，324，2：	1
18	Primary biliary cirrhosis :what we know and what we want to know about human PBC and spontaneous PBC mouse models显示文摘	Ueno Y Moritoki Y Shimosegawa T	2007	J Gastroenterol2007，42，3：	1
19	Primary biliary cirrhosis:what we know and what we want to know about human PBC and spontaneous PBC mouse models 显示文摘	Ueno Y Moritoki Y Shimosegawa T	2007	J Gastroenterol2007，42，3：	1
20	Primary biliary cir-rhosis:what we know and what we want to know about human PBC and spontaneous PBC mouse models 显示文摘	UENO Y MORITOKI Y SHIMOSEGAWA T	2007	J Gastroenterol2007，42，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示